Michelé Annen1, Cynthia Peterson2, Serafin Leemann3, Christof Schmid3, Bernard Anklin3, B Kim Humphreys4. 1. Chiropractic Medicine Student, Chiropractic Medicine Department, Faculty of Medicine, Orthopaedic University Hospital Balgrist, University of Zürich, Zürich, Switzerland. 2. Professor, Chiropractic Medicine Department, Faculty of Medicine, Orthopaedic University Hospital Balgrist, University of Zürich, Zürich, Switzerland. Electronic address: xraydcpeterson@yahoo.ca. 3. Private Practice, Zürich, Switzerland. 4. Professor and Department Head, Chiropractic Medicine Department, Faculty of Medicine, Orthopaedic University Hospital Balgrist, University of Zürich, Zürich, Switzerland.
Abstract
OBJECTIVE: The purpose of this study was to determine if there is a difference in outcomes between Modic positive and negative lumbar disc herniation (LDH) patients treated with spinal manipulative therapy (SMT). METHODS: This prospective outcomes study includes 72 MRI confirmed symptomatic LDH patients treated with SMT. Numerical rating scale (NRS) pain and Oswestry disability data were collected at baseline. NRS, patient global impression of change to assess overall improvement, and Oswestry data were collected at 2 weeks, 1, 3, 6 months and 1 year. MRI scans were analyzed for Modic change present/absent and classified as Modic I or II when present. Chi-squared test compared the proportion of patients reporting relevant 'improvement' between patients with and without Modic changes and those with Modic I vs. II. NRS and Oswestry scores were compared at baseline and change scores at all follow-up time points using the unpaired Student t test. RESULTS: 76.5% of Modic positive patients reported 'improvement' compared to 53.3% of Modic negative patients (P = .09) at 2 weeks. Modic positive patients had larger decreases in leg pain (P = .02) and disability scores (P = .012) at 2 weeks. Modic positive patients had larger reductions in disability levels at 3 (P = .049) and 6 months (P = .001). A significant difference (P = .001) between patients with Modic I vs. Modic II was found at 1 year, where Modic II patients did significantly better. CONCLUSION: Modic positive patients reported higher levels of clinically relevant improvement 2 weeks, 3 and 6 months compared to Modic negative patients. However, at 1 year Modic I patients were significantly less likely to report 'improvement', suggesting they may be prone to relapse.
OBJECTIVE: The purpose of this study was to determine if there is a difference in outcomes between Modic positive and negative lumbar disc herniation (LDH) patients treated with spinal manipulative therapy (SMT). METHODS: This prospective outcomes study includes 72 MRI confirmed symptomatic LDH patients treated with SMT. Numerical rating scale (NRS) pain and Oswestry disability data were collected at baseline. NRS, patient global impression of change to assess overall improvement, and Oswestry data were collected at 2 weeks, 1, 3, 6 months and 1 year. MRI scans were analyzed for Modic change present/absent and classified as Modic I or II when present. Chi-squared test compared the proportion of patients reporting relevant 'improvement' between patients with and without Modic changes and those with Modic I vs. II. NRS and Oswestry scores were compared at baseline and change scores at all follow-up time points using the unpaired Student t test. RESULTS: 76.5% of Modic positive patients reported 'improvement' compared to 53.3% of Modic negative patients (P = .09) at 2 weeks. Modic positive patients had larger decreases in leg pain (P = .02) and disability scores (P = .012) at 2 weeks. Modic positive patients had larger reductions in disability levels at 3 (P = .049) and 6 months (P = .001). A significant difference (P = .001) between patients with Modic I vs. Modic II was found at 1 year, where Modic IIpatients did significantly better. CONCLUSION: Modic positive patients reported higher levels of clinically relevant improvement 2 weeks, 3 and 6 months compared to Modic negative patients. However, at 1 year Modic I patients were significantly less likely to report 'improvement', suggesting they may be prone to relapse.
Authors: Lars Christian Haugli Bråten; Elina Iordanova Schistad; Ansgar Espeland; Per Martin Kristoffersen; Anne Julsrud Haugen; Gunn Hege Marchand; Nils Vetti; Are Hugo Pripp; Thomas Istvan Kadar; Jan Sture Skouen; Margreth Grotle; Lars Grøvle; John-Anker Zwart; Jens Ivar Brox; Kjersti Storheim Journal: BMC Musculoskelet Disord Date: 2020-06-10 Impact factor: 2.362
Authors: Christofer Herlin; Per Kjaer; Ansgar Espeland; Jan Sture Skouen; Charlotte Leboeuf-Yde; Jaro Karppinen; Jaakko Niinimäki; Joan Solgaard Sørensen; Kjersti Storheim; Tue Secher Jensen Journal: PLoS One Date: 2018-08-01 Impact factor: 3.240
Authors: Nick Herger; Paola Bermudez-Lekerika; Mazda Farshad; Christoph E Albers; Oliver Distler; Benjamin Gantenbein; Stefan Dudli Journal: Int J Mol Sci Date: 2022-02-28 Impact factor: 5.923